PC-1 Nucleoside Triphosphate Pyrophosphohydrolase Deficiency in Idiopathic Infantile Arterial Calcification
Overview
Authors
Affiliations
Inogranic pyrophosphate (PPi) inhibits hydroxyapatite deposition, and mice deficient in the PPi-generating nucleoside triphosphate pyrophosphohydrolase (NTPPPH) Plasma cell membrane glycoprotein-1 (PC-1) develop peri-articular and arterial calcification in early life. In idiopathic infantile arterial calcification (IIAC), hydroxyapatite deposition and smooth muscle cell (SMC) proliferation occur, sometimes associated with peri-articular calcification. Thus, we assessed PC-1 expression and PPi metabolism in a 25-month-old boy with IIAC and peri-articular calcifications. Plasma PC-1 was <1 ng/ml by enzyme-linked immunosorbent assay in the proband, but 10 to 30 ng/ml in unaffected family members and controls. PC-1 functioned to raise extracellular PPi in cultured aortic SMCs. However, PC-1 was sparse in temporal artery lesion SMCs in the proband, unlike the case for SMCs in atherosclerotic carotid artery lesions of unrelated adults. Proband plasma and explant-cultured dermal fibroblast NTPPPH and PPi were markedly decreased. The proband was heterozygous at the PC-1 locus, and sizes of PC-1 mRNA and polypeptide, and the PC-1 mRNA-coding region sequence were normal in proband fibroblasts. However, immunoreactive PC-1 protein was relatively sparse in proband fibroblasts. In conclusion, deficient extracellular PPi and a deficiency of PC-1 NTPPPH activity can be associated with human infantile arterial and peri-articular calcification, and may help explain the sharing of certain phenotypic features between some IIAC patients and PC-1-deficient mice.
Homozygous splice-site variant in ENPP1 underlies generalized arterial calcification of infancy.
Noor Ul Ayan H, Nitschke Y, Mughal A, Thiele H, Malik N, Hussain I BMC Pediatr. 2024; 24(1):733.
PMID: 39538190 PMC: 11558987. DOI: 10.1186/s12887-024-05123-0.
Role of ENPP1 in cancer pathogenesis: Mechanisms and clinical implications (Review).
Zhao L, Zhang Y, Tian Y, Ding X, Lin R, Xiao L Oncol Lett. 2024; 28(6):590.
PMID: 39411204 PMC: 11474142. DOI: 10.3892/ol.2024.14722.
Ju O, Ko S, Jang Y Front Cell Dev Biol. 2024; 12:1426762.
PMID: 39291269 PMC: 11405333. DOI: 10.3389/fcell.2024.1426762.
Rutsch F, Salusky I, Ferreira C J Nephrol. 2024; 37(8):2059-2060.
PMID: 39162952 PMC: 11649749. DOI: 10.1007/s40620-024-02057-9.
Quantitative correlation of ENPP1 pathogenic variants with disease phenotype.
Ansh A, Stabach P, Ciccone C, Cao W, De La Cruz E, Sabbagh Y Bone. 2024; 186:117136.
PMID: 38806089 PMC: 11227391. DOI: 10.1016/j.bone.2024.117136.